EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

por Guérin, Olivier, Fischel, Jean Louis, Ferrero, Jean-Marc, Bozec, Alexandre, Milano, Gerard
Publicado 2010

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases

por Braccini, Antoine-Laurent, Azria, David, Thezenas, Simon, Romieu, Gilles, Ferrero, Jean-Marc, Jacot, William
Publicado 2013

Survival analysis of patient groups defined by unsupervised machine learning clustering methods based on patient metabolomic data.

por Bailleux, Caroline, Chardin, David, Guigonis, Jean-Marie, Ferrero, Jean-Marc, Chateau, Yann, Humbert, Olivier, Pourcher, Thierry, Gal, Jocelyn
Publicado 2023

Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study

por Jacquin, Jean-Philippe, Uwer, Lionel, Savignoni, Alexia, Ferrero, Jean-Marc, Lortholary, Alain, Solub, David, Delaporte, Flore, Chalabi, Nassera, Pibre, Sophie, Belkacemi, Yazid
Publicado 2019

Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer

por Bailleux, Caroline, Chardin, David, Gal, Jocelyn, Guigonis, Jean-Marie, Lindenthal, Sabine, Graslin, Fanny, Arnould, Laurent, Cagnard, Alexandre, Ferrero, Jean-Marc, Humbert, Olivier, Pourcher, Thierry
Publicado 2023

Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy

por Genebes, Caroline, Chand, Marie-Eve, Gal, Jocelyn, Gautier, Mathieu, Raoust, Ines, Ihrai, Tarik, Courdi, Adel, Ferrero, Jean-Marc, Peyrottes, Isabelle, Hannoun-Levi, Jean-Michel
Publicado 2014

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progre...

por Gunzer, Katharina, Joly, Florence, Ferrero, Jean-Marc, Gligorov, Joseph, de Mont-Serrat, Helene, Uttenreuther-Fischer, Martina, Pelling, Katy, Wind, Sven, Bousquet, Guilhem, Misset, Jean-Louis
Publicado 2016

DPD status and fluoropyrimidines-based treatment: high activity matters too

por Chamorey, Emmanuel, Francois, Eric, Etienne, Marie-Christine, Ferrero, Jean-Marc, Peyrade, Frederic, Barranger, Emmanuel, Bozec, Alexandre, Largillier, Rémy, Cassuto, Ophelie, Viotti, Julien, Schiappa, Renaud, Milano, Gérard
Publicado 2020

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor–Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis

por Arpino, Grazia, de la Haba Rodríguez, Juan, Ferrero, Jean-Marc, De Placido, Sabino, Osborne, C. Kent, Klingbiel, Dirk, Revelant, Valentine, Wohlfarth, Christine, Poppe, Raf, Rimawi, Mothaffar F.
Publicado 2023

Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer

por Gal, Jocelyn, Bailleux, Caroline, Chardin, David, Pourcher, Thierry, Gilhodes, Julia, Jing, Lun, Guigonis, Jean-Marie, Ferrero, Jean-Marc, Milano, Gerard, Mograbi, Baharia, Brest, Patrick, Chateau, Yann, Humbert, Olivier, Chamorey, Emmanuel
Publicado 2020

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

por Montemagno, Christopher, Hagege, Anais, Borchiellini, Delphine, Thamphya, Brice, Rastoin, Olivia, Ambrosetti, Damien, Iovanna, Juan, Rioux-Leclercq, Nathalie, Porta, Camillio, Negrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Pagès, Gilles, Dufies, Maeva
Publicado 2020

Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer †

por Ferrero, Jean-Marc, Mahammedi, Hakim, Gravis, Gwenaelle, Roubaud, Guilhem, Beuzeboc, Philippe, Largillier, Remi, Borchiellini, Delphine, Linassier, Claude, Ebran, Nathalie, Pace-Loscos, Tanguy, Etienne-Grimaldi, Marie-Christine, Schiappa, Renaud, Gal, Jocelyn, Milano, Gérard
Publicado 2023

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5

por Giuliano, Sandy, Dufies, Maeva, Ndiaye, Papa Diogop, Viotti, Julien, Borchiellini, Delphine, Parola, Julien, Vial, Valérie, Cormerais, Yann, Ohanna, Mickaël, Imbert, Véronique, Chamorey, Emmanuel, Rioux-Leclercq, Nathalie, Savina, Ariel, Ferrero, Jean-Marc, Mograbi, Baharia, Pagès, Gilles
Publicado 2019

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study

por Hardy-Bessard, Anne-Claire, Brocard, Fabien, Clatot, Florian, Lortholary, Alain, You, Benoît, Grenier, Julien, Martin-Babau, Jérôme, Lucas, Brigitte, Meunier, Jérôme, Ferrero, Jean-Marc, Savoye, Aude-Marie, Marti, Adina, Despax, Raymond, Moullet, Isabelle, Emile, George
Publicado 2020

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast...

por Dang, Chau, Ewer, Michael S., Delaloge, Suzette, Ferrero, Jean-Marc, Colomer, Ramon, de la Cruz-Merino, Luis, Werner, Theresa L., Dadswell, Katherine, Verrill, Mark, Eiger, Daniel, Sarkar, Sriparna, de Haas, Sanne Lysbet, Restuccia, Eleonora, Swain, Sandra M.
Publicado 2022

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

por Barrios, Carlos H., Liu, Mei-Ching, Lee, Soo Chin, Vanlemmens, Laurence, Ferrero, Jean-Marc, Tabei, Toshio, Pivot, Xavier, Iwata, Hiroji, Aogi, Kenjiro, Lugo-Quintana, Roberto, Harbeck, Nadia, Brickman, Marla J., Zhang, Ke, Kern, Kenneth A., Martin, Miguel
Publicado 2010

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

por Houédé, Nadine, Beuzeboc, Philippe, Gourgou, Sophie, Tosi, Diego, Moise, Laura, Gravis, Gwenaëlle, Delva, Remy, Fléchon, Aude, Latorzeff, Igor, Ferrero, Jean-Marc, Oudard, Stéphane, Tartas, Sophie, Laguerre, Brigitte, Topart, Delphine, Roubaud, Guilhem, Agherbi, Hanane, Rebillard, Xavier, Azria, David
Publicado 2015

Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes

por Carausu, Marcela, Carton, Matthieu, Diéras, Véronique, Petit, Thierry, Guiu, Séverine, Gonçalves, Anthony, Augereau, Paule, Ferrero, Jean Marc, Levy, Christelle, Ung, Mony, Desmoulins, Isabelle, Debled, Marc, Bachelot, Thomas, Pistilli, Barbara, Frenel, Jean-Sébastien, Mailliez, Audrey, Chevrot, Michaël, Cabel, Luc
Publicado 2022

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

por Polena, Helena, Creuzet, Julie, Dufies, Maeva, Sidibé, Adama, Khalil-Mgharbel, Abir, Salomon, Aude, Deroux, Alban, Quesada, Jean-Louis, Roelants, Caroline, Filhol, Odile, Cochet, Claude, Blanc, Ellen, Ferlay-Segura, Céline, Borchiellini, Delphine, Ferrero, Jean-Marc, Escudier, Bernard, Négrier, Sylvie, Pages, Gilles, Vilgrain, Isabelle
Publicado 2018

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-...

por Tabouret, Emeline, Bertucci, François, Pierga, Jean-Yves, Petit, Thierry, Levy, Christelle, Ferrero, Jean-Marc, Campone, Mario, Gligorov, Joseph, Lerebours, Florence, Roché, Henri, Bachelot, Thomas, van Laere, Steven, Ueno, Naoto T., Toiron, Yves, Finetti, Pascal, Birnbaum, Daniel, Borg, Jean-Paul, Viens, Patrice, Chinot, Olivier, Gonçalves, Anthony
Publicado 2016